Kilitch Drugs touches roof on starting production of Cephalosporin Injectables at Ethiopia Plant

26 Jul 2021 Evaluate

Kilitch Drugs (India) is currently trading at its upper circuit limit of Rs. 200.45, up by 9.50 points or 4.98% from its previous closing of Rs. 190.95 on the BSE.

The scrip opened at Rs. 190.95 and has touched a high and low of Rs. 200.45 and Rs. 184.00 respectively. So far 31383 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 200.45 on 26-Jul-2021 and a 52 week low of Rs. 78.25 on 06-Oct-2020.

Last one week high and low of the scrip stood at Rs. 200.45 and Rs. 162.50 respectively. The current market cap of the company is Rs. 300.81 crore.

The promoters holding in the company stood at 68.33% and Non-Institutions held 31.67%.

Kilitch Drugs India has started production of the Cephalosporin Injectables at Ethiopia manufacturing plant. The company had started its greenfield project in Ethiopia in 2018 to build a world-class Injectable plant.

In early 2021 the company has started production of Antiseptic and Disinfectant products to help Ethiopia fight against the COVID-19 pandemic.

Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms.

Kilitch Drugs(India) Share Price

345.05 -6.25 (-1.78%)
08-Jan-2025 09:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.15
Dr. Reddys Lab 1391.95
Cipla 1504.45
Lupin 2373.00
Zydus Lifesciences 1010.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.